Source link : https://newshealth.biz/health-news/2nd-generation-car-t-shows-benefit/
GLPG5101, a second-generation anti-CD19/4-1BB CAR T-cell therapy, shows high complete response rates in the treatment of high-risk indolent relapsed/refractory (r/r) non-Hodgkin lymphoma, with a notably shortened vein-to-vein time, or time from leukapheresis (the separation and collection of cells) to infusion, compared with other CAR T products. “The short vein-to-vein time of GLPG5101 eliminated the need […]
The post 2nd Generation CAR T Shows Benefit first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-23 10:51:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8